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Abstract
Background: Chronic renal disease is a global health problem. The identification of
suitable biomarkers could facilitate early detection and diagnosis and allow better
understanding of the underlying pathology. One of the challenges in meeting this
goal is the necessary integration of experimental results from multiple biological
levels for further analysis by data mining. Data integration in the life science is still a
struggle, and many groups are looking to the benefits promised by the Semantic
Web for data integration.
Results: We present a Semantic Web approach to developing a knowledge base
that integrates data from high-throughput experiments on kidney and urine. A
specialised KUP ontology is used to tie the various layers together, whilst
background knowledge from external databases is incorporated by conversion into
RDF. Using SPARQL as a query mechanism, we are able to query for proteins
expressed in urine and place these back into the context of genes expressed in
regions of the kidney.
Conclusions: The KUPKB gives KUP biologists the means to ask queries across many
resources in order to aggregate knowledge that is necessary for answering biological
questions. The Semantic Web technologies we use, together with the background
knowledge from the domain’s ontologies, allows both rapid conversion and
integration of this knowledge base. The KUPKB is still relatively small, but questions
remain about scalability, maintenance and availability of the knowledge itself.
Availability: The KUPKB may be accessed via http://www.e-lico.eu/kupkb.
Introduction
The early detection and better understanding of (chronic) renal disease is important as
it will reach pandemic proportions over the next few decades [1]. The biologist’sg o a l
in renal disease is to understand the pathological processes and identify disease bio-
markers. This requires the analyses of experimental data from multiple biological levels
(e.g. genes, proteins and metabolites). These data need to be integrated with existing
knowledge from databases and the scientific literature to connect the different levels.
In addition, the kidney field is peculiar for at least two reasons:
1. the kidney is highly cellular and compartmentalised and each compartment is
involved in many different functions and,
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into the ‘kidney’ context.
All together this makes the analysis of data, for which integration of data is a pre-
requisite, problematic. This paper presents a case-study for developing a knowledge
base around a focused domain in the life sciences, namely the kidney and urinary
pathway (KUP). The KUP Knowledge Base (KUPKB) is being developed as part of the
e-LICO project [2]. e-LICO is developing a data mining platform that supports the
semi-automated construction of data mining workflows for data intensive sciences [3].
The e-LICO platform is to be demonstrated with a system biology use case that uses
real data encountered in the KUP domain. The data spans multiple -omic levels and is
collected from different tissues and from different species. For example, most of the
human -omics data originates from urine [4] and needs to be related back to the kid-
ney and its parts. In contrast, multilevel -omics data from animal models is more regu-
larly available. e-LICO aims to develop tools that will mine these large scale disparate
experimental findings, link those to existing data and build new predictive models for
renal disease.
The KUPKB is built using a Semantic Web approach in order to assess the benefits
and feasibility of creating such a resource with this technology. The methodology sec-
tion guides the reader through the creation of a Kidney and Urinary Pathway Ontology
(KUPO), that provides a specialised application ontology for the KUP domain. The
KUPO provides the schema for the data held in the KUPKB. Within this methodology
we explore the requirements for tools that help engage the biologists in the design and
construction of such an ontology. The results section describes the KUPKB with
examples of the kinds of queries that can be asked across multiple biological levels.
We conclude by discussing the merits and limitations of our approach.
Background
Data integration in the life science is an ongoing challenge in Bioinformatics; problems
arise because standards for data formats, identifiers, common vocabularies and agreed
semantics between databases are lacking [5,6]. Data in the life sciences are complex
and volatile that, when taken with the issues outlined, makes the necessary integration
of life sciences data hard work. Another factor is the numerous data resources pub-
lished by independent groups that leads to an expansion of the heterogeneities that are
rife in life science data [7].
Developing new resources that integrate existing data typically involves centralising
the external data within new bespoke schemas. This ‘warehousing’ approach is com-
mon in the life sciences and over time leads to an increasing number of resources,
each with their own schema [7]. The situation with respect to accessing these data is,
however, improving with data providers often offering programmatic access to the data
via Web Services or database exports [8,9]. This access affords easier integration
opportunities, despite the semantic heterogeneities and the problem of identity of enti-
ties within life science’sd a t a .T h e‘identity crisis’ [10] is being addressed through
efforts such as shared names [11] and services such as BridgeDB [12], but wide spread
compliance has yet to be realised. The adoption of ontologies for the annotation of
data is providing new possibilities for data integration that go beyond using primary
database entry identifiers alone.
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captured. Biological data are complex, heavily inter-related and also often irregular or
incomplete [6,13-15]. Relational databases are good in situations where the data are
regular and complete, and thus are not always suitable for life science data [16-18].
Ontologies offer a potential solution to this problem as they have been demonstrated
to be good at modelling things that are irregular and incomplete [19,20]. Ontologies
are designed to be extensible and can be used to build a conceptualisation of a domain.
An ontology language, such as the Web Ontology Language (OWL) [21], provides a
precise semantics for the language that can be used to check for consistency in data,
along with querying and inference over data. Ontologies have become popular in the
life sciences [22] for the annotation of data and offer novel ways for the analysis and
integration of biological data. Despite the uptake of ontologies for annotating data,
these annotations are often held in more traditional database systems that lack the
necessary support to fully exploit the benefits an ontology brings.
The Semantic Web encompasses many ideas and technologies, but at its heart is the
creation of a connected Web of semantically described data. As opposed to the existing
Web of connected documents, the Semantic Web provides a framework to publish
statements about entities in those documents [23]. At the core of the Semantic Web is
the Resource Description Framework (RDF) [24] that uses Uniform Resource Identi-
fiers (URI) to identify objects on the Web. The RDF data model provides a mechanism
to make statements about these objects in the form of Subject, Predicate and Objects;
these statements are commonly referred to as triples. This simple triple model can be
used to create large connected graphs of data and expose them to application over the
Web. The use of URIs and RDF to expose data on the Web enables the syntactic
integration of data held in biological databases; this model is easily extensible by the
addition of new triples and is not constrained to a particular schema. This light, syn-
tactic reconciliation means that publishing data in RDF is easy. This ease is at least in
part due to the lack of a schema. Using these data, however, can be hard due to the
lack of a schema; this means the heterogeneity in the data still exist and, while a com-
mon syntactic form allows queries across different data represented as RDF, the query
formulator still needs to reconcile the naming and conceptualisation of those data in
order to formulate that query.
RDF alone provides little in the way of semantics for what these objects are and what
the relationships mean. It does, however, offer a means of layering semantic informa-
tion over its simple data model and data published according to that model. At their
heart, ontologies provide a simple service by defining the entities as they appear in a
domain’si n f o r m a t i o n .‘Knowing what there is’ and adopting a common means of
naming and inter-relating ‘what there is’ offers a means of providing a semantic layer
over the syntactic integration of RDF. A common understanding of the types of entities
and the types of relationships between them provides the means to query those data;
that is, ontologies offer a schema-like mechanism for RDF data. The Web Ontology
Language (OWL) provides us with an ontology language that can be expressed using
RDF. OWL ontologies can add semantics to data captured in RDF, these semantics
facilitate a common model for the data, inference and expressive queries over the data.
The work presented in this paper builds on previous efforts to expose life science
data on the Semantic Web. Ruttenburg, Antezana and Cheung giveaw i d e ro v e r v i e w
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Dhanapalan, Sahoo, Hugo and Antezana provide case studies from different domains
for data integration on the Semantic Web [28-31].
Several public databases have been made available as RDF, the Bio2RDF project pro-
vides a repository of over forty biological database already available to download as
RDF [32]. The W3C health care and life sciences working group (HCLS) provide
guidelines and a case-study on Alzheimer’s Disease that was built on Semantic Web
technology [33].
The KUPKB sits within this tradition. The KUPKB is distinguished by its means of
production; we use a series of existing ontologies with a light-weight mechanism for
integrating these ontologies to give a backbone of background knowledge for the KUP
domain in the form of the KUPO. This ‘schema’ is populated with workflows that
bring in the various pre-existing KUP resources.
Methodology
An initial set of experiments were chosen by the KUP scientists for inclusion in the
KUPKB. These experiments span over different biological levels (genes or proteins),
different techniques, different species (mouse or human), and different sample type
(urine or kidney tissue):
1. The Higgins dataset [34] represents gene expression values from seven dissected
compartments of the healthy adult human kidney, analysed by microarray technology.
2. The Chabardés-Garonne [35] dataset represents gene expression values from eight
dissected compartments of the healthy adult human kidney, analysed by the Serial
Analysis of Gene Expression (SAGE) method.
3. The EuReGene dataset [36] represents gene expression values from all the differ-
ent renal structures of the healthy adult mouse kidney, analysed by the in situ hybridi-
sation technique.
4. The Vlahou [37] and the Mann [38] datasets represents protein expression values
from healthy adult human urine, analysed by different mass spectrometry techniques.
For each of these experiments the output is typically a list of genes or proteins of
interest. The initial challenge is to identify proteins found in the urine and related
them back to genes expressed in the kidney. This is made difficult as the data are com-
ing from a range of experiments on both mice and humans. Background knowledge
about genes and proteins is combined with experimental findings to generate new data
for further analysis. The use of ontologies to annotate these data adds value, such as
the ability to generalise over the observations. This combined data will provide input-
data to a series of data-mining experiments within the e-LICO project.
We need the KUPKB to answer a series of queries about biological compounds in
the urine and kidney. To achieve these we need basic information about the
compounds under analysis. Information about genes, proteins and metabolites can be
harvested from publicly available databases. These data must be linked to evidence
coming from the experimental analysis and appropriately annotated to distinguish
between the different experimental factors, such as the biological material or pathologi-
cal state. To tie this data together we need ontologies that describe the relationships
between the various datasets. These will include an ontology for the kidney and urinary
pathway system, experimental analysis and biological databases. We use Semantic Web
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inference. RDF gives us language to represent the data plus a means to publish it on
the Web following Linked Data principles [39]. Ontologies provide both the schema
for the KUPKB and a controlled vocabulary for data annotation. We conceptually
divide the KUPKB into three overlapping sets of ontologies (Figure 1). The first set of
ontologies provides a domain vocabulary for describing the kidney and urinary path-
way. This Kidney and Urinary Pathway Ontology (KUPO) describes the cells of the
kidney in terms of their function and their anatomical locations. The second set
describe the experimental data, this includes descriptions of the experimental results
along with meta-data about the experiment, such as the experimental factors under
observation. The final set of ontologies describe the data obtained from various exter-
nal biological databases.
The life sciences are now rich in ontologies to support our task [22,40]. We can take
advantage of these efforts and use fragments of these ontologies to build the KUPKB.
Re-using existing ontologies in the KUPKB offers many advantages from an integration
point-of-view: by adopting standards and exploiting existing annotation efforts [41] we
have a greater potential for future integration of the KUPKB with other similar
applications.
Kidney and urinary pathway ontology development
The kidney enables the filtration of waste from the blood in the form of urine. Sche-
matically, the kidney can be divided into four major compartments: 1) the glomerular
compartment, involved in blood filtration, 2) the tubular compartment, involved in the
fine tuning of urine composition, 3) the vascular compartment, involved in renal blood
supply and 4) the interstitial compartment that surrounds the other structures. Each
kidney compartment is formed from a wide variety of cell types, and the specificity of
the compartments relies on these specialised cell functions. Depending on the aetiol-
ogy, renal diseases may differentially affect the renal cells and the kidney
Figure 1 Schema overview. Overview of the KUP KB schema showing experimental data connected to
background knowledge and annotated with the KUP ontology
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whereas obstructive nephropathy affects mainly the tubular compartment). It is impor-
tant to link back the disease processes to the anatomical alterations, as it will help not
only to better understand the pathological mechanisms, but also to adapt therapeutic
strategies. For these reasons, the first version of the KUPO imports ontologies to
describe the anatomy, cell types and biological function associated with the cells of the
kidney.
Reference ontologies for the components of the kidney and urinary pathways are
readily available through resources such as OBO foundry [22] and BioPortal [40].
K U P Oi sas e to fO W Lc l a s s e st h a tr e p r e s e n tt h ec e l l so ft h ek i d n e y .T h ec l a s s e sa r e
described using logical definitions that use conceptualisations taken from external
ontologies relevant to the KUP. This modular approach avoids repeating any previous
development efforts, and focuses on extendinga n de n r i c h i n gp r e - e x i s t i n go n t o l o g i e s
where necessary.
Two ontologies were initially considered to describe the anatomy of the kidney: the
Foundational Model of Anatomy (FMA) [42] and the Mouse Adult Gross Anatomy
Ontology (MAO) [43]. Domain experts inspecting the KUP portion of the FMA found
that there was too much detail in some sections and not enough in others. In addition,
too many ontological distinctions were made within this portion of the FMA and the
consequent dispersal of information made it hard for our collaborating biologists to
use. In time, we could have refined views of the FMA to do the job required, but we
found that the MAO had all the detail for our needs. Furthermore, despite the connect-
ing tubule being absent in mouse and present in humans, we still find this concept in
the MAO. Therefore we concluded that the MAO can act as a substitute for the
human anatomy, at least as far as the kidney is concerned.
This approach may be acceptable in the short term. There is, however, the issue that
we effectively label human entities as being mouse entities. A solution would be a spe-
cies neutral vertebrate anatomy, so any renal cell from any vertebrate species could be
labeled as renal cell, and the species recorded elsewhere (see [44]. Efforts such as
CARO (Common Anatomy Reference Ontology) [45] are attempting to provide cross
species reference ontologies for anatomy. The Vertebrate Bridging Ontology (VBO)
project [46] has recently started and we will look to use such efforts in the future.
The Cell Type Ontology (CTO) [47] was the obvious choice for cells, but was found
to be lacking a large number of known renal cell types. A list of new cells was there-
fore generated and cells were described in terms of their anatomical location using the
part_of relationships from the Relations Ontology (RO) [48]. By exploiting the rich
partonomy of the MAO we could use the transitive characteristic of the RO part_of
relationship to describe the renal cells using equivalent class axioms. The logical defini-
tion meant that the complete classification of renal cell types could be computed using
an OWL reasoner. The renal cells were further described in terms of the biological
processes from the Gene Ontology (GO) [49] in which they participate. These new cell
types are to be submitted for inclusion into the CTO.
KUPO development
Populating the KUPO requires detailed domain knowledge about the anatomy and cells
of the kidney. We wanted to explore methodologies that engaged the domain expert in
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powerful, but necessitate a relatively steep learning curve that can be dissuasive for
domain-experts. We attempted to construct the ontology using simple templates that
could be populated by domain experts to gather knowledge about the kidney. Popu-
lated templates were then converted to OWL to produce the KUP ontology.
The templates were generated using a simple spreadsheet, a technique that has
recently become popular in other ontology efforts [51,52]. A KUPO day was also held
as part of a meeting between domain experts from the EuroKUP consortium [53] to
develop and review the knowledge captured in the spreadsheet. These spreadsheets
were validated and transformed into OWL using the Populous tool [54]. Figure 2
shows the KUPO template populated in Populous. A detailed description of Populous
and the KUPO development methodology is available in [54].
Background knowledge
Background knowledge in the KUPKB is composed of various external databases repre-
sented in RDF. Converting existing data into RDF triples is relatively straight forward.
Our methodology closely mimics the development of the HCLS knowledge base [55].
Additionally the Bio2RDF project [32] provides a repository of public databases that
can be downloaded in RDF. These two efforts provided some of the core datasets for
the background biological knowledge represented in the KUPKB.
The initial KUP experiments are concerned with genes and proteins expressed in
kidney and urine samples, while future datasets will be generated from metabolomic
and microRNA studies. We selected the Entrez Gene database [56] for gene annota-
tions and UniProt Knowledgebase [57] for proteins, including the Uniprot Gene Ontol-
ogy annotations [41]. KEGG [58] provides the data for biochemical pathways whilst the
microCosm database [59] provides microRNA target prediction sites. Given that the
Figure 2 Populous. Screenshot of Populous showing template population of the KUP ontology
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orthologous genes that can be obtained from the Homologene database [60].
We wished to capture the relationships between the various entries in these
databases to form a large connected graph of data. Figure 1 gives an outline of how
our background knowledge relates to the KUPO and the experiments. Where possible
we used the Bio2RDF ontology [61] to provide a simple schema for the different
databases.
R D Fr e p r e s e n t a t i o n so fE n t r e zG e n e ,U n i p r o t ,H o m o l o g e n ea n dK E G Gc a nb e
obtained from Bio2RDF. Uniprot KB also provide periodic releases of their database in
RDF. Whilst it was possible take the complete databases and place them directly into
the KUPKB; it was neither necessary or desirable to replicate these databases in their
entirety. Instead we reuse URIs from Bio2RDF and Uniprot KB to reference external
entities in the KUPKB. By re-using URIs from external resources we can expose the
KUPKB as Linked Data and harvest additional data if and when we need it. Resources
in the KUPKB have URIs that resolves to documents on the Web; these documents
provide a description of that resource in RDF and link directly to other documents
that describe the external resources using RDF. This linking connects the KUPKB into
the growing web of linked life science data and highlights one of the major advantages
of a Semantic Web approach.
KUPKB experiments ontology
The KUPKB is required to capture findings from biological experiments such as lists of
interesting genes or proteins expressed under certain conditions. Ontologies such as
O B I[ 6 2 ]a n dE F O[ 6 3 ]p r o v i d ec o n c e p t sf o r the annotation of design, protocols,
instrumentation, materials, experimental factors and data associated with a biomedical
investigation. Despite the extensive coverage of these ontologies, neither provided a
clear way to represent information in gene and protein lists. It is particularly difficult
to attach the appropriate meta-data to these lists in a way that could accommodate a
wide variety of use-cases.
It is beyond the scope of this work to provide a complete modelling solution to this
problem, and work is underway through projects like OBI and the BioRDF task force
of the HCLS working group to create standard modelling patterns for this kind of
data. We opted to build our own ontology to model this data that was simply driven
by requirements of the queries we needed to ask. Though, with a view to future
integration with external ontologies, we followed patterns and reused concepts from
existing ontologies, including OBI, EFO and PATO [64].
Each experiment in the KUPKB is modelled as an instance of a particular ‘experimen-
tal assay type’. Each ‘experimental assay type’ can have multiple ‘experimental analysis’
associated with it. Each ‘experimental analysis’ is annotated with an ‘experimental
factor’ and produces some ‘data’.
For example, the Chabardés-Garonne dataset [35] represents gene expression values
from eight dissected compartments of the healthy adult human kidney. This
experiment is described as a type of ‘Expression Profiling by SAGE’.W ec r e a t e
instances of ‘experiment analysis’ to represent each of the factors under investigation.
In this case, the analysis represents gene expression sets for dissected compartments of
the kidney, as published by the authors. ‘Experimental factors’ can have a related
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role in the experiment (e.g. ‘control’ or ‘analyte’). The resulting ‘gene list’ for a parti-
cular analysis is related to multiple “gene list members’. Each member in a gene lists
can be annotated with additional meta-data such as an external database reference
(e.g. Entrez Gene id for genes). We have adopted terminology from PATO to
describe attributes for the ‘gene list members’ such as ‘postitive regulation’ or ‘pre-
sent’. Figure 3 is an OWL representation of a single gene in the gene list from the
Garonne dataset. We make no claims about our choice of modelling other than it is
sufficient for the kinds of queries we need to ask over the current set of proposed
experiments in the KUPKB.
KUPKB architecture
There are now many options for developers wishing to deploy RDF and OWL data, the
most common approach to date is the use of a triple store. Triple stores provide a fra-
mework for storing and querying RDF data, along with support for varying degrees of
inferencing. One of the major factors in selecting a triple store is scalability. In recent
years triple stores have improve to accommodate large amounts of RDF data (billions
of triples). See here [65,66] for a review of some popular triple stores. We opted to
deploy the KUPKB data using Sesame [67] backed with a storage and inference layer
provided by BigOWLIM [68]. Sesame provides a powerful yet simple framework for
managing and interfacing with the RDF data whilst BigOWLIM provides a fast and
scalable implementation of the Sesame Storage and Inference Layer (SAIL). In order to
expose the KUPKB data as Linked Data, we use the Pubby [69] service. A simple
description of every resource in the KUPKB can be retrieved by its URI as either a
human readable HTML document or plain RDF.
Results
The KUPKB can be queried over the Web via a SPARQL endpoint [70]. The KUPKB
Web page provides some example SPARQL queries to generate interest and harvest
requirements from the wider KUP community. The demo shows how one can query
across multiple data sources using predicates and terminology from the available ontol-
ogies. At the time of writing, the total number of RDF triples in the KUPKB is
10,415,339, whilst the ontologies and experiments describe 24,557 classes and 10,539
individuals. To date no triple stores support the full expressivity of OWL-DL or OWL
2; in order to compensate for this we attempted to compute any inferred knowledge
before loading the data into the knowledge base. We attempted to classify the com-
plete knowledge base with three OWL reasoners; Pellet 2.1.2 [71], Fact++ 1.5.0 [72]
and HerMiT 1.3.1 [73] on a 2 x 2.66GHz Dual Core Intel Xeon Mac Pro with 16GB or
RAM and running OS X server 10.6.4. No reasoner was able to classify the complete
knowledge base in our experiment, however, by excluding the large external databases
we were able to classify the various ontologies along with the experimental data in rea-
sonable time (4.30 min with Fact++). This classification step provided a level of consis-
tency checking and also enabled the computation of missing subsumptions to form the
KUPO class hierarchy.
The first set of demo queries answer simple questions from the KUPO. For example,
‘Which biological processes occur in the kidney collecting duct?’ is answered by getting
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Page 9 of 17Figure 3 Gene lists in OWL. Manchester OWL syntax for the asserted information representing a single
analysis of the Garonne dataset
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GO, and filtering these results on cells that are part of the collecting duct from MAO.
More interestingly, the KUPKB demonstrates how having access to experimental
observations along-side existing domain knowledge could be useful for hypothesis
generation and experimental evaluation. The query ‘Which genes have evidence for
upregulation the glomerulus of a normal adult kidney?’ can now be answered by get-
ting all genes annotated with ‘upregulated’ from all experiments where the condition is
‘normal adult human’ and the bio material is ‘glomerulus’. This kind of query demon-
strates the added value KUPO brings. Not only do we get answers for genes that are
expressed in the glomerulus, but by exploiting the transitive nature of the part_of
relationship, we infer genes upregulated in experiments on any part of the glomerulus.
We can extend this query by exploiting the KUPO to ask for all the cells that are in
parts of the kidney expressing protein involved in some biological process or pathway.
Our final query demonstrates how we can begin to answer real questions from the
KUP scientists. The initial goal was to place protein expressed in urine back into the
context of the kidney. The Vlahou and Mann datasets [37,38] both provide us with
sets of protein identified in urine from normal adult humans. We want to compare
these results with evidence for gene expression in particular compartments of the kid-
ney. Our example query gets all the proteins found in urine across both experiments.
We need to find the intersection of proteins in this list with proteins expressed in both
the Higgins [34] and Garonne [35] datasets. To do this we must first map the genes to
their respective protein using background knowledge in the KUPKB. We can get the
Uniprot identifiers for each gene expressed in the transcriptomics datasets. By combin-
ing these two sets of derived protein we find that 183 proteins have evidence for
expression in seven separate compartments of the kidney. We can further enrich this
list with their appropriate GO annotations to see if there are any patterns observed in
this list. We can now extend this query using data from homologene to bring in the
EuReGene dataset from mice to collect further evidence.
The flexibility offered by KUPKB provides the e-LICO project with a platform to
plan data mining experiments over the KUP data. A recent development from e-LICO
was the initiation of a KUP challenge; this is a challenge for the data mining commu-
nity to learn models from datasets relating to Obstructive Nephropathy (ON) in
children [74]. These datasets are of high dimensionality, but extremely small sample
size. The datasets represent analysis from multiple biological levels including miRNA,
mRNA, proteomics and metabolomics; the challenge is to build a prediction model
from these datasets that uses background knowledge in the KUPKB to connect the
different levels.
Discussion
We have presented an approach to developing a bespoke knowledge base for integrat-
ing biological data relating to the KUP. This KUPKB integrates experimental findings
with background knowledge to provide input for data mining experiments on the
e-LICO platform. The KUPKB differs from more traditional database approaches by its
extensive use of Ontologies and Semantic Web technologies to provide the underlying
data model. The KUPKB is an example of the levels of data integration that can be
achieved once data can be reduced to a common language. Having access to multiple
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platform for data gathering and analysis. The additional semantics provided by the
ontologies offer new and more flexible ways to query and explore the data. Despite the
potential, there are, however, many outstanding issues that continue to stifle develop-
ment in this area.
We found that taking an approach using RDF to gather our data in one form worked
well. As well as taking advantage of existing resources in RDF, conversion of bespoke
K U Pe x p e r i m e n t a ld a t aw a sr e l a t i v e l ys t r a i g ht forward using simple scripts. The main
difficulty was reconciling identifiers across resources; for each experimental dataset we
encountered, a considerable effort was required to map the various identification
schemes between databases. Whilst this was to be expected for the biological data-
bases, it was a surprise to see that little authority exists within the life sciences on the
correct URIs for various ontologies and RDF datasets. For example, we encountered
multiple URIs for common predicates such as the part_of relationship from the OBO
relations ontology.
The KUPKB still has aspects of a warehouse; it gathers resources together in one
place in one form. The KUP ontology is used as a schema for the data. Some of the
dangers of warehouses are, however, avoided. The Semantic Web technologies are tol-
erant, indeed suited for, irregular and incomplete data. Production of data in the
common form of RDF is distributed and much of the task of forming the KUPKB is
the ‘gathering’. The emerging ontological lingua franca makes mapping to a schema
relatively straight-forward. An early requirement for the KUPKB was an ontology that
accurately described the kidney and urinary system. Given the widespread availability
of anatomical ontologies that describe the renal system, we decided to focus on the
cells of the kidney, that previously had little coverage in existing ontologies. The chal-
lenge was to engage the domain experts in the development of such an ontology. We
managed to achieve this by shielding the experts from the underlying ontology build-
ing, and instead gathered knowledge using a simple template approach. The templates
were populated in spreadsheets, an application familiar to the domain scientists. This
approach led to the description of over 180 renal and urinary cell types by domain
experts with little or no ontology building experience.
In order to support the validation of these spreadsheets and their transformation into
an ontology, we developed an application called Populous [54]. Populous enables us to
separate the axiom pattern in the ontology from its population. The pattern itself was
simple, but in a pattern with few axioms and 180 repetitions, we generated an ontology
with several hundred asserted and inferred axioms. The Populous approach allows this
generation to happen quickly and with utter consistency. If the pattern changes, but
with the knowledge the same, then update is equally quick. Any change to the knowl-
edge can be done in the table environment that validates input against constraints.
This first version of KUPO serves its purpose as an application ontology. Questions,
however, still remain about our choice of modelling for this ontology. We used partici-
pates_in to relate a cell to the process in which it is involved, even though we know
this is not necessarily true for all cells of a given type at all times. We could model
that these cells have a disposition that is realised in the biological process, but this
kind of distinction does not add any value to the kinds of queries we want to ask. We
have deliberately moved away from a representation of the“truth” of the biology in
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to plague us in the development of an ontology to describe our experiments.
Developing a common ontology for biomedical experiments and findings is difficult
as the semantics of a biological finding often involve a complex set of interactions. If
we take our gene lists in the KUPKB as an example; these represent some experimental
finding that a biological entity is either present or absent under a certain condition.
The validity of such a statement should take into account a host of factors including
the type of experiment, which instruments were used, how the data was analysed,
along with consideration for less controllable factors such as human error or bias. The
development of appropriate ontologies that capture these various attributes are well
under way, however, progress is inevitably slow due to the complex nature of the task.
For the KUPKB we initially have few requirements for complex descriptions of the
experiments. Datasets are being selected by a relatively small community, and much of
this data is similar enough for cross-comparison. As the KUPKB expands to include
more heterogeneous datasets, more accurate description of the data may well be
required in order to ask more complex queries of the data. Developments in this area
is ongoing and we will contribute experiences from this exercise to the appropriate
ontology efforts. We believe that a relatively simple ontology, similar to our experi-
ments ontology, could provide a model that is “just enough” to achieve more wide
spread integration of this kind of data.
One of the attractive features of adopting ontologies and technologies like OWL is
t h ea b i l i t yt oe x p l o i tt h es e m a n t i c so ft h el a n g u a g et oc h e c kf o rc o n s i s t e n c ya n dd r a w
inferences from the data. Where possible we exploited OWL semantics to drive infer-
ences and reduce the number of manual assertions we needed to make in our ontol-
ogy. This has many advantages from an ontology maintenance point of view and
provides us with with advanced querying capabilities, such as asking for parts of the
renal cortex and returning all the parts right down to the cells. The ability to traverse
transitive relationships is one of the benefits an ontology language can bring; it enables
us to ask general queries such as asking for all cells that participate in cytokine pro-
duction, and by inference would also return cells that participate in specialisations of
cytokine production, such as B cell cytokine production.
Despite the expressive power of OWL queries, we hit a limit when we try to popu-
late these ontologies with instance data; current OWL reasoners do not easily scale to
the volumes of data presented in the KUPKB, which only represents a very small data-
set in comparison to other efforts such as the Alzeimers knowledge base. As a practical
solution to this problem we use an RDF database, which can scale to many billions of
triples, and exploit the limited, but adequate, inferencing capabilities currently on offer.
By moving to an RDF store we lose the ability to ask queries that use higher level
OWL constructs. An RDF query language like SPARQL enables us to explore the
structure of an OWL ontology, but queries soon become complex when working with
class level descriptions. Our chosen RDF store BigOWLIM provides inferencing up to
the level of RDFS along with a fragment of OWL that can be expressed using rules,
such as transitivity and same as. We take the attitude that some answers (that may be
incomplete) are better than no answers from a sound and complete query solution.
The reduction in expressivity within the RDF domain means that the queries asked
may not be as precise; to date we have not yet found this to cause significant
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expressivity of SPARQL with respect to OWL semantics is underway through current
proposals such as SPARQL 1.1 entailment regimes [75,76] and SPARQL-DL [77].
The technical limitations associated with querying a knowledge base like the KUPKB
has an impact on how we build our ontologies and model our data. Most ontologies
for the life science model biological phenomena at the class level. For example, the
class ‘cytokine production’ describes all instances of the process of cytokine production.
If we treat a particular protein record from Uniprot as an instance, then to represent
the relationship in OWL we would type this instance as a member of the class of
things that participate in cytokine production. Representing OWL axioms such as this
in RDF soon becomes verbose and impacts on the complexity of the query. In order to
simplify the query we treat the classes as individuals and create a binary relationship
between the two.
Future work
The KUPKB is to be extended with several datasets from experiments about specific
types of renal disease. These include proteomic analysis of urine from children suffer-
ing obstructive nephropathy. The KUP ontology will be extended to incorporate the
appropriate ontologies that describe the diseases under investigation. These data will
serve as input to data mining experiments within the e-LICO project, with the ultimate
goal of generating new predictive models for renal disease. Early experiments have
shown that we can find useful and interesting correlations in the data pulled from the
KUPKB.
A further issue to tackle is the update of resources. Experiments change; new data
emerge; the ontologies describing these resources change. Keeping resources like the
KUPKB up-to-date will be a struggle. Tools such as Populous will help with re-generating
the ontology, but the mappings to the ontology all have to be managed, exposed and
recorded. In addition, the provenance of the input from all the resources needs to be
recorded to aid scrutiny.
At present we have not recorded much information about the experimental proto-
cols. Currently, the experiments we include in the KUPKB have been chosen by our
participating biologists. In future we will need to describe the experiments such that
scientists can have access to a wide variety of experiments and make the choice them-
selves. This final point of scientists interacting with the KUPKB highlights the need for
good interfaces for querying and browsing such knowledge bases.
Conclusion
We have presented an approach to developing a knowledge base to serve a community
of scientists working on kidney and urinary pathway diseases. We have demonstrated
how a knowledge base such as this can be rapidly developed using state-of-the-art SW
tools. In the KUPKB we have taken advantage of the de facto integration described as
an aim of ontologies such as GO [78], by using the ontologies themselves along with
data annotated with those ontologies to provide an integrated resource of data about
KUP for a community of biologists. The KUPKB can provide useful querying facilities
to biologists and has been relatively easy to produce. There remains much to do, but
we count the work so far as a success.
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